University at Buffalo - The State University of New York
Skip to Content
Richard                        Rabin

Richard A. Rabin PhD

Department of Pharmacology and Toxicology

Professor

Specialty/Research Focus

Apoptosis and cell death; Drug abuse; Molecular and Cellular Biology; Neurobiology; Signal Transduction; Toxicology and Xenobiotics

 
Professional Summary:

My laboratory is focused on understanding the molecular and cellular actions of drugs of abuse such as ethanol and hallucinogens such as lysergic acid diethylamide (LSD). This information is a requisite step in the ultimate development of therapeutic interventions to alleviate the major healthcare and social burden associated with use and abuse of these drugs. In addition, these drugs provide an avenue to explore the basic workings of the brain under pathological conditions that are manifested as various psychiatric disorders. Previous studies, in collaboration with Dr JC Winter in the Dept of Pharmacology and Toxicology at UB, have investigated the roles of the various serotonin receptors subtypes and their associated signaling pathways as well as glutamatergic neurotransmission in the subjective effects of LSD-type hallucinogens. Our other studies have been aimed at understanding the adverse developmental effects of ethanol exposure that result in the fetal alcohol spectrum disorders with the fetal alcohol syndrome (FAS) as the most severe manifestation. Using zebrafish and neuronal cells in culture as model systems, my laboratory in collaboration with Dr CA Dlugos in the Dept of Pathology and Anatomical Sciences at UB have investigated the morphological and histological changes associated with ethanol exposure during different developmental stages as well as the mechanisms by which developmental ethanol exposure causes neuronal loss.

Currently, we are investigating the neurotoxic interaction of ethanol with pesticides. Because of the wide-spread use of pesticides, people are continually exposed both voluntarily and involuntarily to an array of toxic chemicals. In addition, since consumption of alcohol is pervasive in our society with a very high prevalence of alcohol use and abuse, it is extremely likely that people with be co-exposed to both ethanol and pesticides. Because simultaneous or sequential exposure to multiple chemicals can dramatically modify the ensuing toxicological responses, we are using both in vitro (e.g., cells in culture) and in vivo (e.g., zebrafish) model systems to begin assessing the possible health risk of co-exposure to ethanol and pesticides. Using the herbicide paraquat, which is widely used throughout the world, as a test compound, we have found that ethanol synergistically increases the in vitro neurotoxicity of this pesticide. Our efforts are now aimed at ascertaining whether a similar interaction occurs in vivo as well as determining the molecular mechanism responsible for this synergistic neurotoxicity.

Teaching is a naturally complement to research. Accordingly, I have also been engaged in efforts to both improve how we provide the knowledge base to our undergraduate, graduate, and professional students, and also how we help students learn to integrate and apply this information in problem-solving at the clinical and basic science levels. Efforts include: 1. using “clickers” in large class formats to assess student’s understanding of the material and well as provide each student instantaneous feedback for their own self-assessment; 2. using cases studies and a small group learning format; and 3. Having students write short grant proposals based upon the current literature as well as reviewing and critiquing their classmate’s proposals.


Education and Training:
  • PhD, Pharmacology, University of South Carolina School of Medicine (1979)
  • MS, Physiology, Indiana University School of Medicine (1975)
  • BS, Biology, Washington and Lee University (1974)
Employment:
  • Professor, Pharmacology and Toxicology, State University of New York at Buffalo (1996-present)
  • Director, Interdisciplinary Graduate Program in Biomedical Sciences, State University of New York at Buffalo (2001–2009)
  • Associate Professor, Pharmacology and Toxicology, State University of New York at Buffalo (1989–1996)
  • Assistant Professor, Pharmacology and Toxicology, State University of New York at Buffalo (1982–1989)
  • Postdoctoral Fellow, University of Colorado Health Science Center (1979–1982)


Evaluative Studies and Case Reports:
Journal Articles:
  • Dlugos CA, Brown SJ, Rabin RA. Gender differences in ethanol-induced behavioral sensitivity in zebrafish. Alcohol. 2011; 45(1).
  • Miecznikowski JC, Damodaran S, Sellers KF, Rabin RA. A comparison of imputation procedures and statistical tests for the analysis of two-dimensional electrophoresis data. Proteome Sci. 2010; 8.
  • Dlugos CA, Rabin RA. Structural and functional effects of developmental exposure to ethanol on the zebrafish heart. Alcohol Clin Exp Res. 2010; 34(6).
  • Reissig CJ, Rabin RA, Winter JC, Dlugos CA. d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex. Eur J Pharmacol. 2008; 583(1).
  • Reissig CJ, Eckler JR, Rabin RA, Rice KC, Winter JC. The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component. Pharmacol Biochem Behav. 2008; 88(3).
  • Krall CM, Richards JB, Rabin RA, Winter JC. Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice. Pharmacol Biochem Behav. 2008; 88(3).
  • Winter JC, Rice KC, Amorosi DJ, Rabin RA. Psilocybin-induced stimulus control in the rat. Pharmacol Biochem Behav. 2007; 87(4).
  • Dlugos CA. Ocular deficits associated with alcohol exposure during zebrafish development. J Comp Neurol. 2007; 502(4).
  • Damodaran S, Rabin RA. Minimizing variability in two-dimensional electrophoresis gel image analysis. OMICS. 2007; 11(2).
  • Damodaran S, Dlugos CA, Wood TD, Rabin RA. Effects of chronic ethanol administration on brain protein levels: a proteomic investigation using 2-D DIGE system. Eur J Pharmacol. 2006; 547(1-3).
  • Reissig CJ, Eckler JR, Rabin RA, Winter JC. The 5-HT1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology (Berl). 2005; 182(2).
  • Winter JC, Kieres AK, Zimmerman MD, Reissig CJ, Eckler JR, Ullrich T, Rice KC, Rabin RA, Richards JB. The stimulus properties of LSD in C57BL/6 mice. Pharmacol Biochem Behav. 2005; 81(4).
  • Muschamp JW, Regina MJ, Hull EM, Winter JC, Rabin RA. Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Res. 2004; 1023(1).
  • Eckler JR, Reissig CJ, Rabin RA, Winter JC. A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat. Pharmacol Biochem Behav. 2004; 79(1).
  • Regina MJ, Bucelli RC, Winter JC, Rabin RA. Cellular mechanisms of serotonin 5-HT(2A) receptor-mediated cGMP formation: the essential role of glutamate.. Brain Res. 2004; 1003(1-2).
  • Winter JC, Eckler JR, Rabin RA. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.. Psychopharmacology (Berl). 2004; 172(2).
  • Regina MJ, Winter JC, Rabin RA. Characterization of a novel effect of serotonin 5-HT1A and 5-HT2A receptors: increasing cGMP levels in rat frontal cortex.. Neuropharmacology. 2003; 45(8).
  • Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.. Pharmacol Biochem Behav. 2003; 75(4).
  • Eckler JR, Rabin RA, Winter JC. Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.. Pharmacol Biochem Behav. 2003; 75(2).
  • Doat MM, Rabin RA, Winter JC. Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.. Pharmacol Biochem Behav. 2003; 74(3).
  • Dlugos CA, Rabin RA. Ethanol effects on three strains of zebrafish: model system for genetic investigations.. Pharmacol Biochem Behav. 2003; 74(2).
  • Winter JC, Eckler JR, Doat MM, Rabin RA. The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.. Pharmacol Biochem Behav. 2002; 74(1).
  • Eckler JR, Doat MM, Rabin RA, Winter JC. Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: role of pharmacokinetics.. Life Sci. 2002; 71(11).
  • Doat MM, Rabin RA, Winter JC. The effect of chronic treatment with clozapine and haloperidol on stimulus control by DOM.. Int J Neuropsychopharmacol. 2002; 5(2).
  • Rabin RA, Regina M, Doat M, Winter JC. 5-HT(2A) receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.. Pharmacol Biochem Behav. 2002; 72(1-2).
  • Eckler, JR, Richard Rabin, Greizerstein, H, Jerrold Winter. A sensitive method for determining levels of [-]-2,5-dimethoxy-4-methylamphetamine in brain tissue. J Pharmacol Toxicol Methods. 2001; 46.
  • Rabin RA, Doat M, Winter JC. Role of serotonergic 5-HT2A receptors in the psychotomimetic actions of phencyclidine.. Int J Neuropsychopharmacol. 2000; 3(4).
  • Winter JC, Doat M, Rabin RA. Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia.. Life Sci. 2000; 68(3).
  • Winter JC, Filipink RA, Timineri D, Helsley SE, Rabin RA. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.. Pharmacol Biochem Behav. 2000; 65(1).
  • Oberdoerster J, Rabin RA. Enhanced caspase activity during ethanol-induced apoptosis in rat cerebellar granule cells.. Eur J Pharmacol. 1999; 385(2-3).
  • Winter JC, Fiorella DJ, Timineri DM, Filipink RA, Helsley SE, Rabin RA. Serotonergic receptor subtypes and hallucinogen-induced stimulus control.. Pharmacol Biochem Behav. 1999; 64(2).
  • Winter JC, Helsley S, Fiorella D, Rabin RA. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.. Pharmacol Biochem Behav. 1999; 63(3).
  • Helsley S, Rabin RA, Winter JC. Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus.. Prog Neuropsychopharmacol Biol Psychiatry. 1999; 23(2).
  • Oberdoerster J, Rabin RA. NGF-differentiated and undifferentiated PC12 cells vary in induction of apoptosis by ethanol.. Life Sci. 1999; 64(23).
  • Jerrold Winter, Fiorella, DJ, Helsley, SE, Richard Rabin. Partial Generalization of (-)DOM to Fluvoxamine in the Rat: Implications for SSRI-induced Mania and Psychosis. Int J Neuropsychopharmacol. 1999; 2.
  • Helsley S, Siegel TL, Fiorella D, Rabin RA, Winter JC. WAY-100635 reverses 8-OH-DPAT-induced performance impairment in the radial maze.. Prog Neuropsychopharmacol Biol Psychiatry. 1998; 22(7).
  • Oberdoerster J, Kamer AR, Rabin RA. Differential effect of ethanol on PC12 cell death.. J Pharmacol Exp Ther. 1998; 287(1).
  • Winter JC, Helsley SE, Rabin RA. The discriminative stimulus effects of KA 672, a putative cognitive enhancer: evidence for a 5-HT1A component.. Pharmacol Biochem Behav. 1998; 60(3).
  • Helsley S, Fiorella D, Rabin RA, Winter JC. A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.. Prog Neuropsychopharmacol Biol Psychiatry. 1998; 22(4).
  • Helsley S, Rabin RA, Winter JC. The effects of beta-carbolines in rats trained with ibogaine as a discriminative stimulus.. Eur J Pharmacol. 1998; 345(2).
  • Helsley S, Filipink RA, Bowen WD, Rabin RA, Winter JC. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.. Pharmacol Biochem Behav. 1998; 59(2).
  • Helsley S, Fiorella D, Rabin RA, Winter JC. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.. Pharmacol Biochem Behav. 1998; 59(2).
  • Fiorella D, Helsley S, Rabin RA, Winter JC. Further investigations of the interactions of antipsychotics with the (-)2,5-dimethoxy-4-methylamphetamine (DOM) discriminative stimulus.. Neuropharmacology. 1997; 36(10).
  • Helsley S, Fiorella D, Rabin RA, Winter JC. Effects of ibogaine on performance in the 8-arm radial maze.. Pharmacol Biochem Behav. 1997; 58(1).
  • Johnson RG, Fiorella D, Winter JC, Rabin RA. [3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe.. Eur J Pharmacol. 1997; 329(1).
  • Helsley S, Dlugos CA, Pentney RJ, Rabin RA, Winter JC. Effects of chronic ibogaine treatment on cerebellar Purkinje cells in the rat.. Brain Res. 1997; 759(2).
  • Helsley S, Rabin RA, Winter JC. The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus.. Life Sci. 1997; 60(9).
  • Rabin RA, Winter JC. Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors.. Eur J Pharmacol. 1996; 316(2-3).
  • Johnson RG, Severin CM, Rabin RA. Serotonergic binding in the rat dorsal raphe nucleus: critical role of MAO inhibition.. J Pharmacol Toxicol Methods. 1996; 36(2).
  • Rabin RA, Winter JC. Effects of ibogaine and noribogaine on phosphoinositide hydrolysis.. Brain Res. 1996; 731(1-2).
  • Rabin RA. Regulation of the stress-like protein adenotin in PC 12 cells by ethanol exposure.. Biochem Pharmacol. 1996; 51(2).
  • Fiorella D, Helsley S, Rabin RA, Winter JC. Potentiation of LSD-induced stimulus control by fluoxetine in the rat.. Life Sci. 1996; 59(18).
  • Fiorella D, Rabin RA, Winter JC. The interaction of clozapine with the meta-chlorophenylpiperazine (mCPP) discriminative stimulus.. Life Sci. 1996; 58(24).
  • Fiorella D, Helsley S, Rabin RA, Winter JC. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.. Psychopharmacology (Berl). 1995; 122(3).
  • Fiorella D, Helsley S, Lorrain DS, Rabin RA, Winter JC. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.. Psychopharmacology (Berl). 1995; 121(3).
  • Fiorella D, Rabin RA, Winter JC. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.. Psychopharmacology (Berl). 1995; 121(3).
  • Fiorella D, Rabin RA, Winter JC. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.. Psychopharmacology (Berl). 1995; 121(3).
  • Fiorella D, Helsley S, Rabin RA, Winter JC. The interactions of typical and atypical antipsychotics with the (-)2, 5,-dimethoxy-4-methamphetamine (DOM) discriminative stimulus.. Neuropharmacology. 1995; 34(10).
  • Zou JY, Cohan C, Rabin RA, Pentney RJ. Continuous exposure of cultured rat cerebellar macroneurons to ethanol-depressed NMDA and KCl-stimulated elevations of intracellular calcium.. Alcohol Clin Exp Res. 1995; 19(4).
  • Fiorella D, Palumbo PA, Rabin RA, Winter JC. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.. Psychopharmacology (Berl). 1995; 119(2).
  • Fiorella D, Rabin RA, Winter JC. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.. Psychopharmacology (Berl). 1995; 119(2).
  • Bonson KR, Johnson RG, Fiorella D, Rabin RA, Winter JC. Serotonergic control of androgen-induced dominance.. Pharmacol Biochem Behav. 1994; 49(2).
  • Kim WK, Johnson RG, Izu LT, Rabin RA. Chronic ethanol exposure inhibits ATP-stimulated but not KCl-stimulated dopamine release in PC 12 cells.. J Pharmacol Exp Ther. 1994; 270(1).
  • Kim WK, Rabin RA. Characterization of the purinergic P2 receptors in PC12 cells. Evidence for a novel subtype.. J Biol Chem. 1994; 269(9).
  • Desole MS, Kim WK, Rabin RA, Laychock SG. Nitric oxide reduces depolarization-induced calcium influx in PC12 cells by a cyclic GMP-mediated mechanism.. Neuropharmacology. 1994; 33(2).
  • Johnson RG, Fiorella D, Rabin RA. Effects of chronic cocaine administration on the serotonergic system in the rat brain.. Pharmacol Biochem Behav. 1993; 46(2).
  • Kim WK, Hawthorn MH, Rabin RA. Chronic ethanol exposure potentiates muscarinic receptor and alpha 2-adrenoceptor-mediated inhibition of cAMP accumulation in PC 12 cells.. Eur J Pharmacol. 1993; 247(1).
  • Kim WK, Hawthorn M, Rabin RA. Differential effects of chronic ethanol exposure on ATP- and bradykinin-induced increases in intracellular calcium levels in PC-12 cells.. Mol Pharmacol. 1993; 44(2).
  • Winter JC, Rabin RA. Discriminative stimulus properties of m-chlorophenylpiperazine.. Pharmacol Biochem Behav. 1993; 45(1).
  • Rabin RA, Winter JC. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin.. Eur J Pharmacol. 1993; 235(2-3).
  • Rabin RA, Acara MA. Regulation of Na+, K(+)-ATPase by chronic ethanol exposure of PC 12 cells.. Biochem Pharmacol. 1993; 45(8).
  • Winter JC, Rabin RA. Antagonism of the stimulus effects of yohimbine and 8-hydroxydipropylaminotetralin.. Pharmacol Biochem Behav. 1993; 44(4).
  • Zou J, Rabin RA, Pentney RJ. Ethanol enhances neurite outgrowth in primary cultures of rat cerebellar macroneurons.. Brain Res Dev Brain Res. 1993; 72(1).
  • Rabin RA, Fiorella D, Van Wylen DG. Role of extracellular adenosine in ethanol-induced desensitization of cyclic AMP production.. J Neurochem. 1993; 60(3).
  • Rabin RA. Ethanol-induced desensitization of adenylate cyclase: role of the adenosine receptor and GTP-binding proteins.. J Pharmacol Exp Ther. 1993; 264(2).
  • Winter JC, Rabin RA. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination.. J Pharmacol Exp Ther. 1992; 263(2).
  • Rabin RA, Edelman AM, Wagner JA. Activation of protein kinase A is necessary but not sufficient for ethanol-induced desensitization of cyclic AMP production.. J Pharmacol Exp Ther. 1992; 262(1).
  • Edelman AM, Higgins DM, Bowman CL, Haber SN, Rabin RA, Cho-Lee J. Myosin light chain kinase is expressed in neurons and glia: immunoblotting and immunocytochemical studies.. Brain Res Mol Brain Res. 1992; 14.
  • Roth JA, Marcucci K, Lin WH, Napoli JL, Wagner JA, Rabin R. Increase in beta-1,4-galactosyltransferase activity during PC12 cell differentiation induced by forskolin and 2-chloroadenosine.. J Neurochem. 1991; 57(2).
  • Lin WH, Marcucci KA, Rabin RA, Roth JA. 2-Chloroadenosine decreases tyrosylprotein sulfotransferase activity in the Golgi apparatus in PC12 cells. Evidence for a novel receptor.. J Biol Chem. 1991; 266(22).
  • Rabin RA. Chronic ethanol exposure has a dual effect on adenylate cyclase activity and cyclic AMP content.. Ann N Y Acad Sci. 1991; 625.
  • Rabin RA. Direct effects of chronic ethanol exposure on beta-adrenergic and adenosine-sensitive adenylate cyclase activities and cyclic AMP content in primary cerebellar cultures.. J Neurochem. 1990; 55(1).
  • Rabin RA. Chronic ethanol exposure of PC 12 cells alters adenylate cyclase activity and intracellular cyclic AMP content.. J Pharmacol Exp Ther. 1990; 252(3).
  • McCann DJ, Rabin RA, Rens-Domiano S, Winter JC. Phencyclidine/SKF-10,047 binding sites: evaluation of function.. Pharmacol Biochem Behav. 1989; 32(1).
  • Winter J, Rabin R. Yohimbine and serotonergic agonists: Stimulus properties and receptor binding.. Drug Dev. Res.. 1989; 16.
  • Rabin RA. Differential response of adenylate cyclase and ATPase activities after chronic ethanol exposure of PC12 cells.. J Neurochem. 1988; 51(4).
  • Winter JC, Rabin RA. A comparison of the discriminative stimulus properties of l-5-hydroxytryptophan in the presence of either citalopram or Ro 4-4602.. Pharmacol Biochem Behav. 1988; 30(3).
  • Winter JC, Rabin RA. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.. Pharmacol Biochem Behav. 1988; 30(3).
  • Skattebøl A, Rabin RA. Effects of ethanol on 45Ca2+ uptake in synaptosomes and in PC12 cells.. Biochem Pharmacol. 1987; 36(13).
  • McCann DJ, Rabin RA, Winter JC. Use of the radial maze in studies of phencyclidine and other drugs of abuse.. Physiol Behav. 1987; 40(6).
  • McCann DJ, Rabin RA, Winter JC. Interactions of clonidine with phencyclidine and ketamine: studies of radial maze performance and righting reflex in rats.. Pharmacol Biochem Behav. 1987; 26(1).
  • Rabin RA, Bode DC, Molinoff PB. Relationship between ethanol-induced alterations in fluorescence anisotropy and adenylate cyclase activity.. Biochem Pharmacol. 1986; 35(14).
  • Rabin RA. Senescence does not alter activation or inhibition of striatal adenylate cyclase.. Neurobiol Aging. 1986; 7(1).
  • Rabin RA, Bode DC, Molinoff PB. Differential effects of cytosolic modulators of fluoride-stimulated adenylate cyclase activity in striatum and cerebral cortex.. Alcohol Drug Res. 1986; 6(6).
  • Rabin RA. Effect of ethanol on inhibition of striatal adenylate cyclase activity.. Biochem Pharmacol. 1985; 34(24).
  • Pittman RN, Rabin RA, Molinoff PB. Desensitization of beta-adrenergic receptor-coupled adenylate cyclase activity. Differences following exposure of cells to two full agonists.. Biochem Pharmacol. 1984; 33(22).
  • Rabin RA, Allen DO. Role of protein kinase and contractile force in the regulation of myocardial lipolysis.. Horm Metab Res. 1984; 16(9).
  • Rabin RA, Molinoff PB. Multiple sites of action of ethanol on adenylate cyclase.. J Pharmacol Exp Ther. 1983; 227(3).
  • Rabin RA, Molinoff PB. Activation of adenylate cyclase by ethanol in mouse striatal tissue.. J Pharmacol Exp Ther. 1981; 216(1).
  • Ingebretsen CG, Rabin RA, Allen DO. Acetylcholine modulation of phosphorylase and contractility in rat hearts exposed to anoxia or isoproterenol.. Biochem Pharmacol. 1980; 29(12).
  • Rabin RA, Wolfe BB, Dibner MD, Zahniser NR, Melchior C, Molinoff PB. Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice.. J Pharmacol Exp Ther. 1980; 213(3).
  • Dibner MD, Zahniser NR, Wolfe BB, Rabin RA, Molinoff PB. Brain neurotransmitter receptor systems in mice genetically selected for differences in sensitivity to ethanol.. Pharmacol Biochem Behav. 1980; 12(4).
  • Rabin RA, Molinoff PB. Brain neurotransmitter receptor systems in alcohol treated mice and in mice genetically selected for differences in sensitivity to alcohol.. Adv Exp Med Biol. 1980; 132.
See all (93 more)
Books and Book Chapters:
  • Helsley, S, Richard Rabin, Jerrold Winter. Drug discrimination studies with ibogaine. Ibogaine. 1999.


School News:
In the Media:

Clinical Specialties:
Clinical Offices:
Insurance Accepted:


Contact Information

132 Farber Hall
Buffalo, NY 14214
Phone: (716) 829-3286
Email: rarabin@buffalo.edu


Log in to Update Your Profile